ACE Inhibitors: Maybe Not for Hypertension Al...

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-503 Overview: In this episode, we discuss how prescribing “food as medicine” can complement hypertension management in primary care. ...  Show more

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-502 Overview: Abdominal obesity can influence both the severity of menopausal symptoms and treatment decisions. Listen in as we disc ...  Show more

This podcast reviews the pharmaceutical class ACE inhibitors. The therapeutic class is antihypertensives. Discussion of this medication and memory helps to remember this medication are included. 

On this episode, I discuss the pharmacology of calcium channel blockers. There is a few common side effects with these medications and they can lead to the prescribing cascade. I talk about an example in the podcast where they can cause edema which leads to a prescription for a d ...  Show more

In the episode, I break down the pharmacology of lisinopril (and all ACE inhibitors). I also outline common adverse effects, drug interactions and its role in managing hypertension. Hope you enjoy the show and please feel free to reach out with feedback! All subscribers to the we ...  Show more

AHA 2022 Part 1: ISCHEMIA-EXTEND, STRONG-HF, chlorthalidone vs HCTZ, experts vs practitioners; torsemide vs furosemide; and TG lowering are discussed by John Mandrola, MD, in this week's podcast.

This podcast is intended for healthcare professionals only. <u>To ...